跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DURATOCIN carbetocin 100 microgram/mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DURATOCIN carbetocin 100 microgram/mL injection vial
Approved
STANDARD
DURATOCIN carbetocin 100 microgram/mL injection vial
Ferring Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
aa31f06a4c5af1bf
Company
Ferring Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
aa31f06a4c5af1bf
Product Name
DURATOCIN carbetocin 100 microgram/mL injection vial
Artg Id
233671
Artg Name
DURATOCIN carbetocin 100 microgram/mL injection vial
Sponsor
Ferring Pharmaceuticals Pty Ltd
Company Detail Path
/organization/ferring-pharmaceuticals-inc
Artg Date
2015-04-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2a4df013d07dde1c3e30610b80c9f1e6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dda9b1e5569f930ee244a294cd3b08e6.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
aa31f06a4c5af1bf
Type
Standard
Back to TGA Approvals